Home » European Commission Publishes Q&A Leaflet on Biosimilars
European Commission Publishes Q&A Leaflet on Biosimilars
The European Commission has released a new guide to biosimilars.
The patient-focused document covers topics ranging from the definition of a biosimilar to how biosimilars are integrated in treatment, and includes additional sources for patients to review biosimilar products approved in the European Union.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May